The Susquehanna International Group-backed liquidation auction platform got the funding from Spectrum Equity, which is taking two board seats.
Author: Robert Lavine
Translate Bio switches to public listing
The messenger RNA drug developer, backed by Monsanto, Merck & Co, GlaxoSmithKline, Pfizer and Merck Group, has raised more than $121m in its initial public offering.
Lyft picks up $600m at $15bn valuation
Fidelity led the round, bringing the total raised by Lyft, which counts corporates such as GM, Alibaba and Alphabet as backers, to $4.4bn.
Whistle Sports wins $28m
The sports media platform has now raised $93m, after raising series D funds from investors including Liberty Media and Emil Capital.
AISpeech aces latest round
Foxconn and MediaTek contributed to a $75.7m round that speech recognition technology provider AISpeech will use for hiring and product development.
NodThera notches up $37m
The drug developer, which is targeting chronic inflammation-related diseases, has raised series A cash two years after it spun out of Selvita.
Constellation points way to public markets
SR One-backed gene expression technology developer Constellation Pharmaceuticals has filed for an $86.3m initial public offering.
Precision proves effective to close $110m series B
Amgen Ventures, Brace Pharma Capital and Alexandria Venture Investments all invested in the genome editing technology provider.
Go-Jek gets ready for another $1.5bn
The ride services provider, which closed $1.5bn in funding earlier this year, is in talks with Tencent, Google and JD.com for more capital.
TradeIX gets $16m series A transfer
ING Ventures led a round for the blockchain trading technology developer that included fellow corporates BNP Paribas and Tech Mahindra.
Grailed gets a grip on $15m
Existing backer Simon Ventures returned to back a series A round for curated fashion marketplace Grailed, taking its total funding to $20m.
NextFoods gets $12m meal
General Mills subsidiary 301 has led a funding round for probiotics product maker NextFoods that will support product innovation and hiring.
Mercator gets $11m series D infusion
Micro-infusion system developer Mercator MedSystems has received $11m in a round led by Salubris, which has licensed its technology in China.
Henkel hands funding to China Materialia
Open innovation adviser China Materialia has received $5.9m from Henkel Ventures for its second venture capital fund.